Acute and subchronic in-vivo effects of Ferula hermonis L. and Sambucus nigra L. and their potential active isolates in a diabetic mouse model of neuropathic pain

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Raafat, K ^a   El Lakany, A ^a  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

Author keywords

Diabetes mellitus; Ferula hermonis L; in vivo antioxidant; Sambucus nigra L; Tactile allodynia; Thermal hyperalgesia

Indexed keywords

ALCOHOL; FERULA HERMONIS EXTRACT; FERUTININ; GLIBENCLAMIDE; GLUCOSE; KAEMPFEROL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SAMBUCUS NIGRA EXTRACT; TRAMADOL; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ALLODYNIA; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; FERULA; FERULA HERMONIS; GLUCOSE HOMEOSTASIS; HYPERALGESIA; IN VIVO STUDY; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; NEURALGIA; SAMBUCUS NIGRA;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FERULA; HYPOGLYCEMIC AGENTS; MICE; NEURALGIA; PLANT EXTRACTS; SAMBUCUS NIGRA;

EID: 84937838257     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0780-7     Document Type: Article

References (47)

1. WHO. WHO traditional medicine strategy 2002-2005. Geneva: World Health Organization; 2002.
2. Schippmann U, Leaman D, Cunnigham AB. Cultivation and wild collection of medicinal and aromatic plants under sustainability aspects. Dordrecht: Springer (Wageningen UR Frontis); 2006.
3. Saric-Kundalic B, Dobes C, Klatte-Asselmeyer V, Saukel J. Ethnobotanical study on medicinal use of wild and cultivated plants in middle, south and west Bosnia and Herzegovina. J Ethnopharmacol. 2010;131(1):33-55.
4. Gamal-Eldeen AM, Hegazy ME. A crystal lapiferin derived from Ferula vesceritensis induces apoptosis pathway in MCF-7 breast cancer cells. Nat Prod Res. 2010;24(3):246-57.
5. Zanoli P, Rivasi M, Zavatti M, Brusiani F, Vezzalini F, Baraldi M. Activity of single components of Ferula hermonis on male rat sexual behavior. Int J Impot Res. 2005;17(6):513-8.
6. Zavatti M, Montanari C, Zanoli P. Role of ferutinin in the impairment of female sexual function induced by Ferula hermonis. Physiol Behav. 2006;89(5):656-61.
7. Naguib YMA. For reducing weight and therapy of diabetes. In: Google Patents. 2004.
8. Hamdan II, Afifi FU. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J Ethnopharmacol. 2004;93(1):117-21.
9. Abdelkawy KS. Evaluation of the Clinical Effect of Zallouh Extract (Ferula Hermonis) on Diabetic Patients with Erectile Dysfunction. Pan Arab League Dermatol. 2007;18(1):17-26.
10. Veberic R, Jakopic J, Stampar F, Schmitzer V. European elderberry (Sambucus nigra L.) rich in sugars, organic acids, anthocyanins and selected polyphenols. Food Chem. 2009;114:511-5.
11. Halama A, Kulinski M, Librowski T, Lochynski S. Polymer-based non-viral gene delivery as a concept for the treatment of cancer. Pharmacol Rep. 2009;61(6):993-9.
12. Sutovska M, Capek P, Franova S, Pawlaczyk I, Gancarz R. Antitussive and bronchodilatory effects of Lythrum salicaria polysaccharide-polyphenolic conjugate. Int J Biol Macromol. 2012;51(5):794-9.
13. Gray AM, Abdel-Wahab YH, Flatt PR. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J Nutr. 2000;130(1):15-20.
14. Sidor A, Gramza-MichaŁowska A.Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food -a review. J Funct Foods. 2014; doi: 10.1016/j.jff.2014.07.012 .
15. Ciocoiu M, Miron A, Mares L, Tutunaru D, Pohaci C, Groza M, et al. The effects of Sambucus nigra polyphenols on oxidative stress and metabolic disorders in experimental diabetes mellitus. J Physiol Biochem. 2009;65(3):297-304.
16. Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta. 2014;1840(9):2709-29.
17. Viguie CA, Frei B, Shigenaga MK, Ames BN, Packer L, Brooks GA. Antioxidant status and indexes of oxidative stress during consecutive days of exercise. J Appl Physiol (1985). 1993;75(2):566-72.
18. Celep E, Aydin A, Kirmizibekmez H, Yesilada E. Appraisal of in vitro and in vivo antioxidant activity potential of cornelian cherry leaves. Food Chem Toxicol. 2013;62:448-55.
19. Brown AS, Calachanis M, Evdoridis C, Hancock J, Wild S, Prasan A, et al. Sonovue improves endocardial border detection and variability in assessing wall motion score and ejection fraction during stress echocardiography. Ir J Med Sci. 2004;173(1):13-7.
20. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
21. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
22. Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol Res. 2009;60(1):24-32.
23. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43(8):957-73.
24. Tesfaye S. Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig. 2011;2(1):33-42.
25. Raafat K, Aboul-Ela M, El-Lakany A. Alloxan-induced diabetic thermal hyperalgesia, prophylaxis and phytotherapeutic effects of Rheum ribes L. in mouse model. Arch Pharm Res. 2014. Epub ahead on print.
26. Raafat K, Samy W. Amelioration of Diabetes and Painful Diabetic Neuropathy by Punica granatum L. Extract and Its Spray Dried Biopolymeric Dispersions. Evid Based Complement Alternat Med. 2014;2014:180495.
27. Raafat K, Breitinger U, Mahran L, Ayoub N, Breitinger H-G. Synergistic Inhibition of Glycinergic Transmission In Vitro and In Vivo by Flavonoids and Strychnine. Toxicol Sci. 2010;118:171-82.
28. Raafat KM, Jassar H, Aboul-Ela M, El-Lakany A. Protective effects of Origanum majorana L. against Neurodegeneration: Fingerprinting, Isolation and In vivo Glycine Receptors Behavioral Model. I J Phytomed. 2013;5(1):46-57.
29. U.S. Office of Science and Technology Policy. Laboratory animal welfare; U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training; notice. Fed Regist. 1985;50(97):20864-5.
30. Bakirel T, Bakirel U, Keles OU, Ulgen SG, Yardibi H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol. 2008;116(1):64-73.
31. Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, et al. Mouse models of diabetic neuropathy. Neurobiol Dis. 2007;28(3):276-85.
32. Ulugol A, Oltulu C, Gunduz O, Citak C, Carrara R, Shaqaqi MR, et al. 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. Pharmacol Biochem Behav. 2012;102(2):344-8.
33. Fox A, Gentry C, Patel S, Kesingland A, Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain. 2003;105(1-2):355-62.
34. Yasmineh WG, Kaur TP, Blazar BR, Theologides A. Serum catalase as marker of graft-vs-host disease in allogeneic bone marrow transplant recipients: pilot study. Clin Chem. 1995;41(11):1574-80.
35. Breitinger U, Raafat KM, Breitinger HG. Glucose is a positive modulator for the activation of human recombinant glycine receptors. J Neurochem. 2015. doi: 10.1111/jnc.13215 . Epub ahead of print.
36. Said G. Diabetic neuropathy--a review. Nat Clin Pract Neurol. 2007;3(6):331-40.
37. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93.
38. Widenfalk J, Wu W, Hao J, Person JK, Wiesenfeldt-Hallin Z, Risling M. Treatment of transected peripheral nerves with artemin improved motor neuron regeneration, but did not reduce nerve injury-induced pain behaviour. Scand J Plast Reconstr Surg Hand Surg. 2009;43(5):245-50.
39. Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents based approach. J Ethnopharmacol. 2013;150(1):51-70.
40. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48(1):1-9.
41. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med. 1995;18(5):833-40.
42. Abdala S, Dévora S, Martín-Herrera D, Pérez-Paz P. Antinociceptive and anti-inflammatory activity of Sambucus palmensis link, an endemic Canary Island species. J Ethnopharmacol. 2014;155(1):626-32.
43. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes Metab. 2007;9(6):799-812.
44. Raafat K, Boukhary R, Aboul-Ela M, El-Lakany A. Endogenous Lebanese Plants Treating Diabetes and Related Complications. Nat Prod Chem Res. 2013;1(3):112-20.
45. Sepici-Dincel A, Acikgoz S, Cevik C, Sengelen M, Yesilada E. Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol. 2007;110(3):498-503.
46. Al-Azzawie HF, Alhamdani MS. Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 2006;78(12):1371-7.
47. Al-Ja'fari AH, Vila R, Freixa B, Tomi F, Casanova J, Costa J, et al. Composition and antifungal activity of the essential oil from the rhizome and roots of Ferula hermonis. Phytochemistry. 2011;72(11-12):1406-13.